Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

HLMEX vs. HLEZX: which is better?

Bottom line

HLMEX vs HLEZX: the short answer

HLMEX and HLEZX are two share classes of the same fund — Harding Loevner Institutional Emerging Markets Portfolio — so they hold the identical portfolio. The differences are cost, minimums and how you buy them.

HLEZX is cheaper at 0.95% vs 1.05% — a difference of $10 a year per $10,000 invested.

Over five years, HLEZX returned −0.4% a year vs −0.4% for HLMEX.

Updated Nov 19, 2026

HLMEX vs HLEZX side by side

HLMEXHLEZX
TypeMutual fundMutual fund
Fund familyHarding LoevnerHarding Loevner
CategoryEmerging MarketsEmerging Markets
Expense ratio1.05%0.95%
Annual cost per $10k$105$95
10-yr cost on $10k (prospectus)$1,389$1,305
Max front load0%0%
12b-1 fee0%0%
1-yr return+28.4%+28.5%
5-yr return (annualized)−0.4%−0.4%
10-yr return (annualized)+5.7%+5.9%
Best quarter+22.7%+22.7%
Worst quarter−27.6%−27.6%
Net assets (fund)$492.2M$492.2M
Number of holdings7272
Portfolio turnover25%25%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearHLMEXHLEZXDifference
2025+28.4%+28.5%−0.1%
2024+2.7%+2.8%−0.1%
2023+6.2%+6.2%−0.1%
2022−27.7%−27.6%−0.1%
2021−3.4%−3.3%−0.1%
2020+13.9%+14.0%−0.2%
2019+25.8%+26.0%−0.2%
2018−18.6%−18.5%−0.1%
2017+35.3%+35.8%−0.5%
2016+13.3%+13.4%−0.2%

Source: Fund prospectus bar charts

FAQ

What is the difference between HLMEX and HLEZX?
HLMEX and HLEZX are two share classes of the same fund — Harding Loevner Institutional Emerging Markets Portfolio — so they hold the identical portfolio. The differences are cost, minimums and how you buy them. HLEZX is cheaper at 0.95% vs 1.05% — a difference of $10 a year per $10,000 invested.
Which is cheaper, HLMEX or HLEZX?
HLEZX has the lower expense ratio (0.95%).
Should I own both HLMEX and HLEZX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.